BioCentury
ARTICLE | Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

January 9, 2019 9:18 PM UTC

Paul-Peter Tak has stepped down from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to join Flagship Pioneering as a venture partner. He was GSK's SVP of R&D, chief immunology officer and development lead.

Evercore ISI hired Ravi Mehrotra as senior managing director for biotechnology equity research. Mehrotra was a partner at MTS Health Partners...